» Articles » PMID: 38238369

CuO Nanoparticles for Green Synthesis of Significant Anti-Helicobacter Pylori Compounds with in Silico Studies

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jan 18
PMID 38238369
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori (H. pylori) is a universal health intimidation as mentioned by the World Health Organization. The primary causal agent linked to a number of illnesses, including inflammation and the development of stomach ulcers, is Helicobacter pylori. Since, H. pylori develops antibiotic resistance quickly, current H. pylori treatment approaches are becoming less effective. Our research aims to highlight novel formulation antibiotics using CuO-NPs as catalysts and studied their activity as anti-helicobacter pylori supported by computational studies (POM analysis and molecular docking) software. They were designed for anti-Helicobacter Pylori action. All compounds revealed a bactericidal effect better than the reference McFarland standards.

Citing Articles

Antibacterial Properties of Copper Oxide Nanoparticles (Review).

Gudkov S, Burmistrov D, Fomina P, Validov S, Kozlov V Int J Mol Sci. 2024; 25(21).

PMID: 39519117 PMC: 11547097. DOI: 10.3390/ijms252111563.


Biosynthesis of CuO nanoparticle using leaf extracts of Ocimum lamiifolium Hochst. ex Benth and Withana somnifera (L) Dunal for antibacterial activity.

Mengesha S, Abebe G, Habtemariam T Sci Rep. 2024; 14(1):23870.

PMID: 39396068 PMC: 11470964. DOI: 10.1038/s41598-024-75296-2.


Discovery of Novel and Selective Schiff Base Inhibitors as a Key for Drug Synthesis, Molecular Docking, and Pharmacological Evaluation.

Khan I, Rehman W, Rasheed L, Rahim F, Hussain R, Khan S ACS Omega. 2024; 9(28):31148-31158.

PMID: 39035878 PMC: 11256303. DOI: 10.1021/acsomega.4c04599.


Pharmacokinetic and molecular docking studies to pyrimidine drug using MnO nanoparticles to explore potential anti-Alzheimer activity.

Shehab W, Haikal H, Elsayed D, El-Farargy A, El-Gazzar A, El-Bassyouni G Sci Rep. 2024; 14(1):15436.

PMID: 38965280 PMC: 11224222. DOI: 10.1038/s41598-024-65166-2.


Synthesis of CuO, ZnO nanoparticles, and CuO-ZnO nanocomposite for enhanced photocatalytic degradation of Rhodamine B: a comparative study.

Jeevarathinam M, Asharani I Sci Rep. 2024; 14(1):9718.

PMID: 38678108 PMC: 11577056. DOI: 10.1038/s41598-024-60008-7.


References
1.
Yan J, Peng C, Chen P, Zhang W, Jiang C, Sang S . In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts. J Ethnopharmacol. 2021; 283:114578. DOI: 10.1016/j.jep.2021.114578. View

2.
Cardos I, Zaha D, Sindhu R, Cavalu S . Revisiting Therapeutic Strategies for Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules. 2021; 26(19). PMC: 8512130. DOI: 10.3390/molecules26196078. View

3.
Eaton K, Morgan D, Krakowka S . Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun. 1989; 57(4):1119-25. PMC: 313239. DOI: 10.1128/iai.57.4.1119-1125.1989. View

4.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet D . Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2017; 18(3):318-327. DOI: 10.1016/S1473-3099(17)30753-3. View

5.
Sharma A, Sheyi R, de la Torre B, El-Faham A, Albericio F . s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation. Molecules. 2021; 26(4). PMC: 7914932. DOI: 10.3390/molecules26040864. View